GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...

After years of limited activity, the digital health sector is finally showing signs of life in the public markets. Only a few companies have filed to go public in recent years, including Waystar ...

WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn't adapt fast enough to a rapidly ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both ...

After spending nearly two decades in the financial payments sector before transitioning to healthcare, I feel that I’ve gained unique insights into how principles from traditional financial ...

Data and system integration is less glamorous compared to the latest conversations on how AI can improve healthcare delivery and outcomes. However, for AI or other technologies to be successful, a ...

Every minute matters in healthcare. Outdated systems and disjointed workflows can stall the flow of critical clinical information. Today’s providers often face the challenge of retrieving vital ...